Search Results

There are 10480 results for: content related to: Effects of repeated treatment with MDMA on working memory and behavioural flexibility in mice

  1. You have free access to this content
    Mechanisms mediating the ability of caffeine to influence MDMA (‘Ecstasy’)-induced hyperthermia in rats

    British Journal of Pharmacology

    Volume 160, Issue 4, June 2010, Pages: 860–877, N Vanattou-Saïfoudine, R McNamara and A Harkin

    Article first published online : 24 MAY 2010, DOI: 10.1111/j.1476-5381.2010.00660.x

  2. You have free access to this content
    The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives

    British Journal of Pharmacology

    Volume 160, Issue 5, July 2010, Pages: 1029–1044, JR Docherty and AR Green

    Article first published online : 3 MAR 2010, DOI: 10.1111/j.1476-5381.2010.00722.x

  3. MDMA and Other “Club Drugs”

    Standard Article

    Handbook of Contemporary Neuropharmacology

    M. Isabel Colado, Esther O'Shea and A. Richard Green

    Published Online : 2 MAR 2007, DOI: 10.1002/9780470101001.hcn039

  4. Adolescent pre-exposure to ethanol and 3,4-methylenedioxymethylamphetamine (MDMA) increases conditioned rewarding effects of MDMA and drug-induced reinstatement

    Addiction Biology

    Volume 17, Issue 3, May 2012, Pages: 588–600, Bruno Ribeiro Do Couto, Manuel Daza-Losada, Marta Rodríguez-Arias, Roser Nadal, Consuelo Guerri, Teresa Summavielle, Jose Miñarro and Maria A. Aguilar

    Article first published online : 13 OCT 2011, DOI: 10.1111/j.1369-1600.2011.00382.x

  5. The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA (“Ecstasy”) in Humans

    Clinical Pharmacology & Therapeutics

    Volume 90, Issue 2, August 2011, Pages: 246–255, CM Hysek, LD Simmler, M Ineichen, E Grouzmann, MC Hoener, R Brenneisen, J Huwyler and ME Liechti

    Article first published online : 15 JUN 2011, DOI: 10.1038/clpt.2011.78

  6. You have free access to this content
    MDMA ‘ecstasy’ increases cerebral cortical perfusion determined by bolus-tracking arterial spin labelling (btASL) MRI

    British Journal of Pharmacology

    Volume 169, Issue 5, July 2013, Pages: 974–987, J Rouine, O L Gobbo, M Campbell, V Gigliucci, I Ogden, K McHugh Smith, P Duffy, B Behan, D Byrne, M E Kelly, C W Blau, C M Kerskens and A Harkin

    Article first published online : 12 JUN 2013, DOI: 10.1111/bph.12178

  7. You have free access to this content
    Methylenedioxymethamphetamine inhibits mitochondrial complex I activity in mice: a possible mechanism underlying neurotoxicity

    British Journal of Pharmacology

    Volume 160, Issue 2, May 2010, Pages: 233–245, Elena Puerta, Isabel Hervias, Beatriz Goñi-Allo, Steven F Zhang, Joaquín Jordán, Anatoly A Starkov and Norberto Aguirre

    Article first published online : 23 MAR 2010, DOI: 10.1111/j.1476-5381.2010.00663.x

  8. You have free access to this content
    Microglial and astroglial activation by 3,4-methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility

    Journal of Neurochemistry

    Volume 124, Issue 1, January 2013, Pages: 69–78, Lucia Frau, Nicola Simola, Antonio Plumitallo and Micaela Morelli

    Article first published online : 15 NOV 2012, DOI: 10.1111/jnc.12060

  9. You have free access to this content
    Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): a stressor on the immune system

    Immunology

    Volume 111, Issue 4, March 2004, Pages: 357–367, Thomas J. Connor

    Article first published online : 30 MAR 2004, DOI: 10.1111/j.0019-2805.2004.01847.x

  10. You have free access to this content
    Methylenedioxymethamphetamine (‘Ecstasy’)-induced immunosuppression: a cause for concern?

    British Journal of Pharmacology

    Volume 161, Issue 1, September 2010, Pages: 17–32, Noreen T Boyle and Thomas J Connor

    Article first published online : 25 MAY 2010, DOI: 10.1111/j.1476-5381.2010.00899.x

  11. Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases

    Human Psychopharmacology: Clinical and Experimental

    Volume 27, Issue 4, July 2012, Pages: 352–363, Cecilie L. Licht, Maria Christoffersen, Mads Okholm, Lærke Damgaard, Anders Fink-Jensen, Gitte M. Knudsen and David Erritzoe

    Article first published online : 14 JUN 2012, DOI: 10.1002/hup.2234

  12. Fluoxetine pretreatment effects pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, ECSTASY) in rat

    Journal of Pharmaceutical Sciences

    Volume 97, Issue 4, April 2008, Pages: 1593–1605, Vijay V. Upreti and Natalie D. Eddington

    Article first published online : 27 AUG 2007, DOI: 10.1002/jps.21045

  13. Recovery and aging of serotonergic fibers after single and intermittent MDMA treatment in dark agouti rat

    Journal of Comparative Neurology

    Volume 519, Issue 12, 15 August 2011, Pages: 2353–2378, Csaba Ádori, Rómeó D. Andó, Mária Szekeres, Lise Gutknecht, Gábor G. Kovács, László Hunyady, Klaus-Peter Lesch and György Bagdy

    Article first published online : 27 JUN 2011, DOI: 10.1002/cne.22631

  14. (±)3,4-methylenedioxymethamphetamine (“ecstasy”) treatment modulates expression of neurotrophins and their receptors in multiple regions of adult rat brain

    Journal of Comparative Neurology

    Volume 520, Issue 11, 1 August 2012, Pages: 2459–2474, Ann M. Hemmerle, Jonathan W. Dickerson, Nicole R. Herring, Tori L. Schaefer, Charles V. Vorhees, Michael T. Williams and Kim B. Seroogy

    Article first published online : 14 MAY 2012, DOI: 10.1002/cne.23048

  15. You have free access to this content
    Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans

    British Journal of Pharmacology

    Volume 166, Issue 8, August 2012, Pages: 2277–2288, CM Hysek, Y Schmid, A Rickli, LD Simmler, M Donzelli, E Grouzmann and ME Liechti

    Article first published online : 24 JUL 2012, DOI: 10.1111/j.1476-5381.2012.01936.x

  16. MDMA is certainly damaging after 25 years of empirical research: a reply and refutation of Doblin et al. (2014)

    Human Psychopharmacology: Clinical and Experimental

    Volume 29, Issue 2, March 2014, Pages: 109–119, Andrew C. Parrott

    Article first published online : 3 MAR 2014, DOI: 10.1002/hup.2390

  17. You have free access to this content
    Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research

    Human Psychopharmacology: Clinical and Experimental

    Volume 28, Issue 4, July 2013, Pages: 289–307, Andrew C. Parrott

    Article first published online : 23 JUL 2013, DOI: 10.1002/hup.2318

  18. Influences of the corticotropic axis and sympathetic activity on neurochemical consequences of 3,4-methylenedioxymethamphetamine (MDMA) administration in Fischer 344 rats

    European Journal of Neuroscience

    Volume 16, Issue 4, August 2002, Pages: 607–618, Francesca Fernandez, Sylvie Aguerre, Pierre Mormède and Francis Chaouloff

    Article first published online : 19 SEP 2002, DOI: 10.1046/j.1460-9568.2002.02110.x

  19. You have free access to this content
    Lost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans

    British Journal of Pharmacology

    Volume 166, Issue 5, July 2012, Pages: 1523–1536, AR Green, MV King, SE Shortall and KCF Fone

    Article first published online : 21 JUN 2012, DOI: 10.1111/j.1476-5381.2011.01819.x

  20. PRECLINICAL STUDY: Atypical development of behavioural sensitization to 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) in adolescent rats and its expression in adulthood: role of the MDMA chirality

    Addiction Biology

    Volume 15, Issue 1, January 2010, Pages: 35–44, Nora Von Ameln and Andreas Von Ameln-Mayerhofer

    Article first published online : 8 DEC 2009, DOI: 10.1111/j.1369-1600.2009.00187.x